Infarct volume after hyperacute infusion of hypertonic saline in a rat model of acute embolic stroke

Neurocritical Care

Volumn 18, Issue 1, 2013, Pages 106-114

  Papangelou, Alexander ^a   Toung, Thomas J K ^a   Gottschalk, Allan ^a   Mirski, Marek A ^a   Koehler, Raymond C ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Embolic stroke; Hypernatremia; Hypertonic saline; Normal saline; Tissue water content; Wistar rats

Indexed keywords

SODIUM; SODIUM CHLORIDE;

ACUTE EMBOLIC STROKE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BRAIN CORTEX; BRAIN INFARCTION SIZE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; INFUSION; INTERNAL CAROTID ARTERY; INTRACRANIAL PRESSURE MONITORING; LASER DOPPLER FLOWMETRY; LEFT HEMISPHERE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; OSMOLARITY; PRIORITY JOURNAL; PUTAMEN; RAT; REPERFUSION; RIGHT HEMISPHERE; SODIUM BLOOD LEVEL; WATER CONTENT;

ANIMALS; BRAIN; BRAIN EDEMA; BRAIN INFARCTION; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; INTRACRANIAL EMBOLISM; LASER-DOPPLER FLOWMETRY; MALE; RATS; RATS, WISTAR; SALINE SOLUTION, HYPERTONIC;

EID: 84873460427     PISSN: 15416933     EISSN: 15560961     Source Type: Journal    
DOI: 10.1007/s12028-012-9768-z     Document Type: Article

References (64)

1. Ducey JP, Mozingo DW, Lamiell JM, Okerburg C, Gueller GE. A comparison of the cerebral and cardiovascular effects of complete resuscitation with isotonic and hypertonic saline, hetastarch, and whole blood following hemorrhage. J Trauma. 1989;29:1510-8.
2. Fisher B, Thomas D, Peterson B. Hypertonic saline lowers raised intracranial-pressure in children after head trauma. J Neurosurg Anesthesiol. 1992;4:4-10.
3. Francony G, Fauvage B, Falcon D, Canet C, Dilou H, Lavagne P, et al. Equimolar doses of mannitol and hypertonic saline in the treatment of increased intracranial pressure. Crit Care Med. 2008;36:795-800.
4. Gemma M, Cozzi S, Tommasino C, Mungo M, Calvi MR, Cipriani A, et al. 7.5 % hypertonic saline versus 20 % mannitol during elective neurosurgical supratentorial procedures. J Neurosurg Anesthesiol. 1997;9:329-34.
5. Koenig MA, Bryan M, Lewin JL 3rd, Mirski MA, Geocadin RG, Stevens RD. Reversal of transtentorial herniation with hypertonic saline. Neurology. 2008;70:1023-9.
6. Qureshi AI, Wilson DA, Traystman RJ. Treatment of elevated intracranial pressure in experimental intracerebral hemorrhage: comparison between mannitol and hypertonic saline. Neurosurgery. 1999;44:1055-63; discussion 1063-4.
7. Schwarz S, Georgiadis D, Aschoff A, Schwab S. Effects of hypertonic (10 %) saline in patients with raised intracranial pressure after stroke. Stroke. 2002;33:136-40.
8. Schwarz S, Schwab S, Bertram M, Aschoff A, Hacke W. Effects of hypertonic saline hydroxyethyl starch solution and mannitol in patients with increased intracranial pressure after stroke. Stroke. 1998;29:1550-5.
9. Simma B, Burger R, Falk M, Sacher P, Fanconi S. A prospective, randomized, and controlled study of fluid management in children with severe head injury: lactated Ringer's solution versus hypertonic saline. Crit Care Med. 1998;26:1265-70.
10. Suarez JI, Qureshi AI, Bhardwaj A, Williams MA, Schnitzer MS, Mirski M, et al. Treatment of refractory intracranial hypertension with 23.4 % saline. Crit Care Med. 1998;26:1118-22.
11. Suarez JI, Qureshi AI, Parekh PD, Razumovsky A, Tamargo RJ, Bhardwaj A, et al. Administration of hypertonic (3 %) sodium chloride/acetate in hyponatremic patients with symptomatic vasospasm following subarachnoid hemorrhage. J Neurosurg Anesthesiol. 1999;11:178-84.
12. Toung TJ, Hurn PD, Traystman RJ, Bhardwaj A. Global brain water increases after experimental focal cerebral ischemia: effect of hypertonic saline. Crit Care Med. 2002;30:644-9.
13. Toung TJ, Tyler B, Brem H, Traystman RJ, Hurn PD, Bhardwaj A. Hypertonic saline ameliorates cerebral edema associated with experimental brain tumor. J Neurosurg Anesthesiol. 2002;14:187-93.
14. Worthley LI, Cooper DJ, Jones N. Treatment of resistant intracranial hypertension with hypertonic saline. Report of two cases. J Neurosurg. 1988;68:478-81.
15. Kerwin AJ, Schinco MA, Tepas JJ 3rd, Renfro WH, Vitarbo EA, Muehlberger M. The use of 23.4 % hypertonic saline for the management of elevated intracranial pressure in patients with severe traumatic brain injury: a pilot study. J Trauma. 2009;67:277-82.
16. Raghavan M, Marik PE. Therapy of intracranial hypertension in patients with fulminant hepatic failure. Neurocrit Care. 2006;4:179-89.
17. Bhardwaj A, Harukuni I, Murphy SJ, Alkayed NJ, Crain BJ, Koehler RC, et al. Hypertonic saline worsens infarct volume after transient focal ischemia in rats. Stroke. 2000;31:1694-701.
18. Chen CH, Toung TJ, Sapirstein A, Bhardwaj A. Effect of duration of osmotherapy on blood-brain barrier disruption and regional cerebral edema after experimental stroke. J Cereb Blood Flow Metab. 2006;26:951-8.
19. Yang GY, Betz AL. Reperfusion-induced injury to the blood-brain barrier after middle cerebral artery occlusion in rats. Stroke. 1994;25:1658-64; discussion 1664-5.
20. Alkayed NJ, Harukuni I, Kimes AS, London ED, Traystman RJ, Hurn PD. Gender-linked brain injury in experimental stroke. Stroke. 1998;29:159-65; discussion 166.
21. Zhang RL, Chopp M, Zhang ZG, Jiang Q, Ewing JR. A rat model of focal embolic cerebral ischemia. Brain Res. 1997;766:83-92.
22. Takahashi H, Kirsch JR, Hashimoto K, London ED, Koehler RC, Traystman RJ. PPBP [4-phenyl-1-(4-phenylbutyl) piperidine] decreases brain injury after transient focal ischemia in rats. Stroke. 1996;27:2120-3.
23. Lin TN, He YY, Wu G, Khan M, Hsu CY. Effect of brain edema on infarct volume in a focal cerebral ischemia model in rats. Stroke. 1993;24:117-21.
24. Swanson RA, Morton MT, Tsao-Wu G, Savalos RA, Davidson C, Sharp FR. A semiautomated method for measuring brain infarct volume. J Cereb Blood Flow Metab. 1990;10:290-3.
25. Toung TJ, Nyquist P, Mirski MA. Effect of hypertonic saline concentration on cerebral and visceral organ water in an uninjured rodent model. Crit Care Med. 2008;36:256-61.
26. Lee JY, Sagher O, Keep R, Hua Y, Xi G. Comparison of experimental rat models of early brain injury after subarachnoid hemorrhage. Neurosurgery. 2009;65:331-43; discussion 343.
27. Kahles T, Foerch C, Sitzer M, Schroeter M, Steinmetz H, Rami A, et al. Tissue plasminogen activator mediated blood-brain barrier damage in transient focal cerebral ischemia in rats: relevance of interactions between thrombotic material and thrombolytic agent. Vascul Pharmacol. 2005;43:254-9.
28. Zeynalov E, Chen CH, Froehner SC, Adams ME, Ottersen OP, Amiry-Moghaddam M, et al. The perivascular pool of aquaporin-4 mediates the effect of osmotherapy in postischemic cerebral edema. Crit Care Med. 2008;36:2634-40.
29. Tseng MY, Al-Rawi PG, Pickard JD, Rasulo FA, Kirkpatrick PJ. Effect of hypertonic saline on cerebral blood flow in poor-grade patients with subarachnoid hemorrhage. Stroke. 2003;34:1389-96.
30. Muizelaar JP, Wei EP, Kontos HA, Becker DP. Cerebral blood flow is regulated by changes in blood pressure and in blood viscosity alike. Stroke. 1986;17:44-8.
31. Paczynski RP. Osmotherapy. Basic concepts and controversies. Crit Care Clin. 1997;13:105-29.
32. Heimann A, Takeshima T, Alessandri B, Noppens R, Kempski O. Effects of hypertonic/hyperoncotic treatment after rat cortical vein occlusion. Crit Care Med. 2003;31:2495-501.
33. Shackford SR, Zhuang J, Schmoker J. Intravenous fluid tonicity: effect on intracranial pressure, cerebral blood flow, and cerebral oxygen delivery in focal brain injury. J Neurosurg. 1992;76:91-8.
34. Hartl R, Medary MB, Ruge M, Arfors KE, Ghahremani F, Ghajar J. Hypertonic/hyperoncotic saline attenuates microcirculatory disturbances after traumatic brain injury. J Trauma. 1997;42:S41-7.
35. Forsyth LL, Liu-DeRyke X, Parker D Jr, Rhoney DH. Role of hypertonic saline for the management of intracranial hypertension after stroke and traumatic brain injury. Pharmacotherapy. 2008;28:469-84.
36. Ciesla DJ, Moore EE, Zallen G, Biffl WL, Silliman CC. Hypertonic saline attenuation of polymorphonuclear neutrophil cytotoxicity: timing is everything. J Trauma. 2000;48:388-95.
37. Cuschieri J, Gourlay D, Garcia I, Jelacic S, Maier RV. Hypertonic preconditioning inhibits macrophage responsiveness to endotoxin. J Immunol. 2002;168:1389-96.
38. Loomis WH, Namiki S, Hoyt DB, Junger WG. Hypertonicity rescues T cells from suppression by trauma-induced anti-inflammatory mediators. Am J Physiol Cell Physiol. 2001;281:C840-8.
39. Rhee P, Wang D, Ruff P, Austin B, DeBraux S, Wolcott K, et al. Human neutrophil activation and increased adhesion by various resuscitation fluids. Crit Care Med. 2000;28:74-8.
40. Rizoli SB, Kapus A, Fan J, Li YH, Marshall JC, Rotstein OD. Immunomodulatory effects of hypertonic resuscitation on the development of lung inflammation following hemorrhagic shock. J Immunol. 1998;161:6288-96.
41. Coimbra R, Junger WG, Hoyt DB, Liu FC, Loomis WH, Evers MF. Hypertonic saline resuscitation restores hemorrhage-induced immunosuppression by decreasing prostaglandin E2 and interleukin-4 production. J Surg Res. 1996;64:203-9.
42. Coimbra R, Junger WG, Liu FC, Loomis WH, Hoyt DB. Hypertonic/hyperoncotic fluids reverse prostaglandin E2 (PGE2)-induced T-cell suppression. Shock. 1995;4:45-9.
43. Gushchin V, Stegalkina S, Alam HB, Kirkpatrick JR, Rhee PM, Koustova E. Cytokine expression profiling in human leukocytes after exposure to hypertonic and isotonic fluids. J Trauma. 2002;52:867-71.
44. Junger WG, Coimbra R, Liu FC, Herdon-Remelius C, Junger W, Junger H, et al. Hypertonic saline resuscitation: a tool to modulate immune function in trauma patients? Shock. 1997;8:235-41.
45. Attuwaybi B, Kozar RA, Gates KS, Moore-Olufemi S, Sato N, Weisbrodt NW, et al. Hypertonic saline prevents inflammation, injury, and impaired intestinal transit after gut ischemia/reperfusion by inducing heme oxygenase 1 enzyme. J Trauma. 2004;56:749-58; discussion 758-9.
46. Gurfinkel V, Poggetti RS, Fontes B, da Costa Ferreira Novo F, Birolini D. Hypertonic saline improves tissue oxygenation and reduces systemic and pulmonary inflammatory response caused by hemorrhagic shock. J Trauma. 2003;54:1137-45.
47. Powers KA, Zurawska J, Szaszi K, Khadaroo RG, Kapus A, Rotstein OD. Hypertonic resuscitation of hemorrhagic shock prevents alveolar macrophage activation by preventing systemic oxidative stress due to gut ischemia/reperfusion. Surgery. 2005;137:66-74.
48. Shields CJ, Winter DC, Manning BJ, Wang JH, Kirwan WO, Redmond HP. Hypertonic saline infusion for pulmonary injury due to ischemia-reperfusion. Arch Surg. 2003;138:9-14.
49. Angle N, Cabello-Passini R, Hoyt DB, Loomis WH, Shreve A, Namiki S, et al. Hypertonic saline infusion: can it regulate human neutrophil function? Shock. 2000;14:503-8.
50. Bulger EM, Cuschieri J, Warner K, Maier RV. Hypertonic resuscitation modulates the inflammatory response in patients with traumatic hemorrhagic shock. Ann Surg. 2007;245:635-41.
51. Kolsen-Petersen JA, Nielsen JO, Bendtzen K, Tonnesen E. Infusion of hypertonic saline (7.5 % NaCl) causes minor immunological changes in normovolaemic women. Acta Anaesthesiol Scand. 2004;48:224-33.
52. Kolsen-Petersen JA, Nielsen JO, Tonnesen EM. Effect of hypertonic saline infusion on postoperative cellular immune function: a randomized controlled clinical trial. Anesthesiology. 2004;100:1108-18.
53. Huang PP, Stucky FS, Dimick AR, Treat RC, Bessey PQ, Rue LW. Hypertonic sodium resuscitation is associated with renal failure and death. Ann Surg. 1995;221:543-54; discussion 554-7.
54. Suarez JI. Hypertonic saline for cerebral edema and elevated intracranial pressure. Cleve Clin J Med. 2004;71(Suppl 1):S9-13.
55. Wagner I, Hauer EM, Staykov D, Volbers B, Dorfler A, Schwab S, et al. Effects of continuous hypertonic saline infusion on perihemorrhagic edema evolution. Stroke. 2011;42:1540-5.
56. Hauer EM, Stark D, Staykov D, Steigleder T, Schwab S, Bardutzky J. Early continuous hypertonic saline infusion in patients with severe cerebrovascular disease. Crit Care Med. 2011;39:1766-72.
57. Qureshi AI, Suarez JI, Bhardwaj A, Mirski M, Schnitzer MS, Hanley DF, et al. Use of hypertonic (3 %) saline/acetate infusion in the treatment of cerebral edema: effect on intracranial pressure and lateral displacement of the brain. Crit Care Med. 1998;26:440-6.
58. Froelich M, Ni Q, Wess C, Ougorets I, Hartl R. Continuous hypertonic saline therapy and the occurrence of complications in neurocritically ill patients. Crit Care Med. 2009;37:1433-41.
59. Riggs JE. Neurologic manifestations of electrolyte disturbances. Neurol Clin. 2002;20:227-39, vii.
60. Castilla-Guerra L, del Carmen Fernandez-Moreno M, Lopez-Chozas JM, Fernandez-Bolanos R. Electrolytes disturbances and seizures. Epilepsia. 2006;47:1990-8.
61. Handy JM, Soni N. Physiological effects of hyperchloraemia and acidosis. Br J Anaesth. 2008;101:141-50.
62. Yunos NM, Bellomo R, Story D, Kellum J. Bench-to-bedside review: chloride in critical illness. Crit Care. 2010;14:226.
63. McFarlane C, Lee A. A comparison of plasmalyte 148 and 0.9 % saline for intra-operative fluid replacement. Anaesthesia. 1994;49:779-81.
64. Reed RL 2nd, Johnston TD, Chen Y, Fischer RP. Hypertonic saline alters plasma clotting times and platelet aggregation. J Trauma. 1991;31:8-14.